All Stories

  1. Local authority commissioning of NHS Health Checks: a regression analysis of the first three years
  2. Investigating the impact of primary care payments on underdiagnosis in dementia: A difference-in-differences analysis
  3. Directors of public health as ‘a protected species’: qualitative study of the changing role of public health professionals in England following the 2013 reforms
  4. Integrated Care: A Pill for All Ills?
  5. Risk of Care Home Placement following Acute Hospital Admission: Effects of a Pay-for-Performance Scheme for Dementia
  6. Bridging the gap
  7. Erratum to: Variations in Performance of Mental Health Providers in the English NHS: An Analysis of the Relationship Between Readmission Rates and Length-of-Stay
  8. Variations in Performance of Mental Health Providers in the English NHS: An Analysis of the Relationship Between Readmission Rates and Length-of-Stay
  9. Paying for the quantity and quality of hospital care: the foundations and evolution of payment policy in England
  10. Determinants of hospital length of stay for people with serious mental illness in England and implications for payment systems: a regression analysis
  11. Does the quality and outcomes framework reduce psychiatric admissions in people with serious mental illness? A regression analysis
  12. Do higher primary care practice performance scores predict lower rates of emergency admissions for persons with serious mental illness? An analysis of secondary panel data
  13. The Influence of Primary Care Quality on Hospital Admissions for People with Dementia in England: A Regression Analysis
  14. Integrating funds for health and social care: an evidence review
  15. RELATIVE EFFECTIVENESS IN BREAST CANCER TREATMENT: A HEALTH PRODUCTION APPROACH
  16. UNDERSTANDING VARIATIONS IN RELATIVE EFFECTIVENESS: A HEALTH PRODUCTION APPROACH
  17. Hospital admissions for severe mental illness in England: Changes in equity of utilisation at the small area level between 2006 and 2010
  18. Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review
  19. Topical treatments for chronic plaque psoriasis of the scalp: a systematic review
  20. Prioritizing investment in public health and health equity: what can commissioners do?
  21. Topical treatments for chronic plaque psoriasis
  22. Collaborative palliative care for advanced heart failure: outcomes and costs from the ‘Better Together’ pilot study
  23. WHY DO PATIENTS HAVING CORONARY ARTERY BYPASS GRAFTS HAVE DIFFERENT COSTS OR LENGTH OF STAY? AN ANALYSIS ACROSS 10 EUROPEAN COUNTRIES
  24. HOW WELL DO DIAGNOSIS-RELATED GROUPS FOR APPENDECTOMY EXPLAIN VARIATIONS IN RESOURCE USE? AN ANALYSIS OF PATIENT-LEVEL DATA FROM 10 EUROPEAN COUNTRIES
  25. Using QALYs in Cancer
  26. Navigating uncharted waters? How international experience can inform the funding of mental health care in England
  27. A Review of Diagnostic Process and Postdiagnostic Support for People With Dementia in Rural Areas
  28. Incentivizing preventive services in primary care: perspectives on Local Enhanced Services
  29. Comparison of Anticancer Drug Coverage Decisions in the United States and United Kingdom: Does the Evidence Support the Rhetoric?
  30. Private sector treatment centres are treating less complex patients than the NHS
  31. Sexual precocity in a 4 year old boy
  32. Value for money and the Quality and Outcomes Framework in primary care in the UK NHS
  33. Are English treatment centres treating less complex patients?
  34. Public funding of new cancer drugs: Is NICE getting nastier?
  35. Topical treatments for chronic plaque psoriasis
  36. Should prospective payments be differentiated for public and private healthcare providers?
  37. Rationing new medicines in the UK
  38. Establishing the economics of engaging communities in health promotion: what is desirable, what is feasible?
  39. Factors affecting the uptake of new medicines in secondary care a literature review
  40. Systematic searches for the effectiveness of respite care
  41. New medicines in primary care: a review of influences on general practitioner prescribing
  42. The hospital costs of care for stroke in nine European countries
  43. In Reply
  44. A systematic review of the effectiveness and cost-effectiveness of different models of community-based respite care for frail older people and their carers
  45. The Effectiveness and Cost-Effectiveness of Respite for Caregivers of Frail Older People
  46. European Perspective on the Costs and Cost-Effectiveness of Cancer Therapies
  47. Costs and prices for inpatient care in England: Mirror twins or distant cousins?
  48. The desirability and feasibility of economic studies of drugs post-launch
  49. The Generalisability of Pharmacoeconomic Studies
  50. Publishing outcome data: is it an effective approach?
  51. Does the English NHS have a ‘Health Benefit Basket’?
  52. Prescribing Incentive Schemes
  53. Influencing prescribing in English primary care: the views of primary care organisations
  54. Topical treatments for chronic plaque psoriasis
  55. Optometrist prescribing of therapeutic agents: findings of the AESOP survey
  56. Topical preparations for the treatment of psoriasis: a systematic review
  57. Joint Disease Management Ventures in the UK
  58. Is disease management relevant in Europe: some evidence from the United Kingdom
  59. Cost to the NHS of accidents to children in the West Midlands